This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
The Subsidiary has received one inspectional observation in Form 483
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
The positive opinions are based on applications submitted by Biosimilar Collaborations Ireland Limited
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
